[1]
Fanoudi, S. et al. 2018. Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats. EXCLI Journal. 17, (Oct. 2018), 999–1017. DOI:https://doi.org/10.17179/excli2018-1626.